批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/12/19 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/09/01 |
SUPPL-52(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/04/10 |
SUPPL-51(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/25 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/25 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/04/03 |
SUPPL-49(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/03/13 |
SUPPL-46(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2012/03/13 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/08/31 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/08/31 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/07/29 |
SUPPL-39(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2003/07/14 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2003/07/14 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/12/20 |
SUPPL-10(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2002/11/15 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/08/26 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/06/21 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/11/26 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/08/08 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/05/14 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/04/23 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/12/26 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/12/11 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/11/09 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/08/25 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/06/02 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/01/24 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1999/10/08 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/07/16 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/03/22 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/12/09 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/11/01 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/07/31 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/06/23 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/06/05 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:LATANOPROST 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:0.005% 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020597 |
001 |
NDA |
XALATAN |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
Yes |
Yes |
AT |
1996/06/05
|
UPJOHN |
091449 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
SANDOZ |
200925 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
AMRING PHARMS |
201006 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
BAUSCH AND LOMB |
201786 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2011/03/22
|
SOMERSET |
090887 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Discontinued |
No |
No |
AT |
2011/07/19
|
EPIC PHARMA LLC |
202077 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2013/02/11
|
RYAN LABS |
202442 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2016/04/22
|
FDC LTD |
218257 |
001 |
ANDA |
LATANOPROST |
LATANOPROST |
SOLUTION/DROPS;OPHTHALMIC |
0.005% |
Prescription |
No |
No |
AT |
2024/11/26
|
GLAND |